Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today congratulated trusted Edwards partner Dr. Albert Starr on receiving the 2015 Institut de France’s Grand Prix Scientifique in a Paris awards ceremony.
The Grand Prix is one of the largest prizes for scientific accomplishment and is considered the world’s most prestigious prize for cardiovascular research. The Institut’s board awarded Starr the Grand Prix in recognition of research that led to the world’s first successful artificial mitral valve implant in 1960. In the last 55 years, millions of patients around the world have benefitted from the emergence of the field of heart valve replacement and the many technological advances that followed.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7536851-france-grand-prix-starr-edwards/
The National Inventors Hall of Fame®, in partnership with the United States Patent and Trademark Office (USPTO), will host the Greatest Celebration of American Innovation on May 3-4 in our Nation’s Capital. Events will recognize and celebrate 15 pioneers who have significantly contributed to society through their scientific breakthroughs and patented innovations, culminating in a formal Induction Ceremony on May 4.
This year’s class of Inductees includes innovators such as Iver Anderson (Lead-Free Solder), Marshall Jones (Industrial Lasers), Frances Ligler (Portable Optical Biosensors), and Howard Head (Laminate Ski; Oversized Tennis Racket), just to name a few. To view the full list of 2017 Inductees, visit: http://prn.to/2lgdW84.
To view the multimedia release go to:
https://www.multivu.com/players/English/8040951-national-inventors-hall-of-fame-2017/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
Learning science company McGraw-Hill Education today announced the launch of Redbird Language Arts & Writing, a new enhanced personalized learning program that helps students master language arts concepts and build strong foundational writing skills. The new program accomplishes this by combining innovative writing analysis technology, interactive practice and personalized learning. The supplemental curriculum, for grades 2-7 and at-risk secondary students, is available to U.S. schools nationwide.
Originally developed by Stanford University, Redbird’s adaptive learning technology provides a personalized learning experience for each student. Redbird Language Arts & Writing delivers immediate feedback and charts an optimized path through the program based on each individual student’s skillset and level of progress – while also empowering educators with real-time, data-driven insights about their students’ learning.
To view the multimedia release go to:
https://www.multivu.com/players/English/7782356-mcgraw-hill-education-redbird/
Bestselling author Catherynne M. Valente (The Girl Who Circumnavigated Fairyland in a Ship of Her Own Making etc) returns to adult fiction with an eagerly awaited new novel: RADIANCE. She applies the phenomenal talent that made the Fairyland series so popular to give readers what she describes as a decopunk pulp science fiction alt-history space opera mystery set in a Hollywood—and solar system—very different from our own. http://www.catherynnemvalente.com YA, Fantasy, SciFi
5 Reasons To Buy An Electric Car. Driving the 2016 Nissan Leaf, I discuss the many benefits of driving an electric vehicle. The instant torque and peak torque from 0 RPM, the incredibly low maintenance (tire rotations and cabin filter changes), the incredible efficiency (about 3x the efficiency of an ICE vehicle), the convenience of charging, and the affordability of leasing an electric car.
Related Videos
Nissan Leaf Review - https://youtu.be/KovdnzywQbs
Free Car? - https://youtu.be/NCdLFhUmubc
References:
Tribology International Study - http://www.sciencedirect.com/science/article/pii/S0301679X11003501
Fuel Economy Study - https://www.fueleconomy.gov/feg/evtech.shtml
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
www.LegendsofAmunRa.com
One of the best science fiction books of the year is here, The Soul of the World, book 2 in the series Legends of Amun Ra
The ancient powers lost to Potara have returned. The Brotherhood of the Black Rose rises to bring Thoth into disorder. And, while the Brotherhood reclaims their power, chaos reigns among the survivors. Six individuals have emerged from the aftermath struggling for control over their lives and a divided land. Kem and Shirin, who abolished the five thousand year reign of the Amun Priests, rule from the golden throne of the Oracle’s Chair in the Hall of the Nine. Dio and Axios struggle to piece together a resistance worthy to challenge the ancient magic which resides in the Great Temple of Amun, and Leoros and Atlantia try to remain true to their hearts and their cause despite tragedy.
But when the Book of Breathings is discovered, the path to immortality is revealed. Leoros and Kem race to capture the Soul of the World unaware of the challenges awaiting them. This time, the gods themselves will intervene. A must read, best science fiction books of the year
In a tale where boys become men and girls become women, where treachery and deception are around every corner, and where primeval mysticism finds its way back from the grave, victory is reserved for neither the good nor the evil, but the powerful.
Join the journey to one of the best science fiction books in 2013.
www.LegendsofAmunRa.com
Today, WebMD released My Abuelita Told Me, a new five-part video series developed in partnership with Dr. Juan Rivera (“Dr. Juan”), a board-certified internist and cardiologist, who is well-known for his best-selling books and regular appearances on broadcast television. My Abuelita Told Me explores the reliability of the various home remedies, beliefs and established practices that beloved abuelitas (a.k.a. grandmas) have passed down through the generations, and Dr. Juan clarifies what is or isn’t accurate using medical science.
To view the multimedia release go to:
https://www.multivu.com/players/English/7579758-webmd-my-abuelita-told-me-bilingual-video-series/
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
It is estimated that almost 40 percent of men and women in the U.S. will be diagnosed with cancer sometime during their lifetime. Kommah, who was diagnosed at age 29, now has her health and her son, thanks to discoveries made at City of Hope, where scientists and doctors turn laboratory breakthroughs into treatments that defeat cancer.
Today, the nonprofit research and comprehensive cancer center near Los Angeles is rolling out a new initiative that builds on its legacy of discovery to let people know that City of Hope not only offers a uniquely patient-centric, integrated approach to care, but also with the help of donors and volunteers, it is pursuing research that will change the future of medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7665051-city-of-hope-miracle-science-soul-campaign/
